Evidence map›Paper›PMID 25383888›Full record

ArticlePloS one2014

Resequencing microarray technology for genotyping human papillomavirus in cervical smears.

Nicolas Berthet, Michael Falguières, Claudia Filippone, Chloé Bertolus, Christine Bole-Feysot, Sylvain Brisse, Antoine Gessain, Isabelle Heard, Michel Favre

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Nicolas BerthetInstitut Pasteur, Epidémiologie et Physiopathologie des Virus Oncogènes, 75724 Paris Cedex 15, France; Centre National de la Recherche Scientifique, UMR 3569, 75724 Paris Cedex 15, France.
Michael FalguièresInstitut Pasteur, Centre National de Référence des Papillomavirus, 75724 Paris Cedex 15, France.
Claudia FilipponeInstitut Pasteur, Epidémiologie et Physiopathologie des Virus Oncogènes, 75724 Paris Cedex 15, France; Centre National de la Recherche Scientifique, UMR 3569, 75724 Paris Cedex 15, France.
Chloé BertolusAP-HP, Hôpital Pitié-Salpêtrière, Service de Chirurgie Maxillo-Faciale et Stomatologie, 75013 Paris, France; UPMC, Université Paris 06, CIMI-Paris, UMRS CR7, INSERM U1135, 75005, Paris, France.
Christine Bole-FeysotImagine, Institut des maladies génétiques - Plateforme Génomique, Hôpital Necker - Enfants Malades, 75743 Paris cedex 15, France.
Sylvain BrisseInstitut Pasteur, Plate-forme Génotypage des Pathogènes et Santé Publique, 75724 Paris Cedex 15, France.
Antoine GessainInstitut Pasteur, Epidémiologie et Physiopathologie des Virus Oncogènes, 75724 Paris Cedex 15, France; Centre National de la Recherche Scientifique, UMR 3569, 75724 Paris Cedex 15, France.
Isabelle HeardInstitut Pasteur, Centre National de Référence des Papillomavirus, 75724 Paris Cedex 15, France; UPMC Université Paris 06, Groupe hospitalier Pitié-Salpêtrière, Paris Cedex 13, France.
Michel FavreInstitut Pasteur, Centre National de Référence des Papillomavirus, 75724 Paris Cedex 15, France; Institut Pasteur, Unité de Génétique, Papillomavirus et Cancer humain, 75724 Paris Cedex 15, France.
Institut Pasteur · FRCentre de Gestion Scientifique · FRCentre National de la Recherche Scientifique · FRHôpital Necker-Enfants Malades · FRInserm · FRPitié-Salpêtrière Hospital · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are more than 40 human papillomaviruses (HPVs) belonging to the alpha genus that cause sexually transmitted infections; these infections are among the most frequent and can lead to condylomas and anogenital intra-epithelial neoplasia. At least 18 of these viruses are causative agents of anogenital carcinomas. We evaluated the performance of a resequencing microarray for the detection and genotyping of alpha HPV of clinical significance using cloned HPV DNA. To reduce the number of HPV genotypes tiled on microarray, we used reconstructed ancestral sequences (RASs) as they are more closely related to the various genotypes than the current genotypes are among themselves. The performance of this approach was tested by genotyping with a set of 40 cervical smears already genotyped using the commercial PapilloCheck kit. The results of the two tests were concordant for 70% (28/40) of the samples and compatible for 30% (12/40). Our findings indicate that RASs were able to detect and identify one or several HPV in clinical samples. Associating RASs with homonym sequences improved the genotyping of HPV present in cases of multiple infection. In conclusion, we demonstrate the diagnostic potential of resequencing technology for genotyping of HPV, and illustrate its value both for epidemiological studies and for monitoring the distribution of HPV in the post-vaccination era.

Indexed as

PhylogenyAlphapapillomavirusBase SequenceCluster AnalysisDNA PrimersDNA, ViralFemaleGenotypeHumansMolecular Sequence DataOligonucleotide Array Sequence AnalysisReal-Time Polymerase Chain ReactionSequence Analysis, DNAVaginal SmearsDNA PrimersDNA, Viral

Identifiers

PMID25383888
PMCPMC4226468
OpenAlexW2072108412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.